The Hepatic Reductase Null (HRN (TM)) and Reductase Conditional Null (RCN) mouse models as suitable tools to study metabolism, toxicity and carcinogenicity of environmental pollutants
Abstract
The cytochrome P450 (P450) superfamily consists of a large number of haem-containing mono-oxygenases that play a pivotal role in the metabolism of many drugs and carcinogens. A number of gene knockout and transgenic mice have been developed to study the role of specific P450 isoenzymes in xenobiotic metabolism, but the functional redundancy inevitably found in the P450 gene superfamily make it difficult to determine the in vivo role of these enzymes in xenobiotic metabolism as a whole.
Over ten years ago the Hepatic Reductase Null (HRN(TM)) model was developed to overcome these limitations. In these mice cytochrome P450 oxidoreductase (POR), the electron donor to P450 enzymes, is deleted specifically in hepatocytes, resulting in the loss of essentially all hepatic P450 function.
While the HRN model uses an hepatocyte-specific albumin promoter to drive POR deletion during mouse development to adulthood, adult Reductase Conditional Null (RCN) mice are entirely normal with respect to POR (and thus P450 function) until hepatic POR deletion is driven via a CYP1A1 promoter which is induced by treatment with the polycyclic aromatic hydrocarbon 3-methylcholanthrene, essentially recapitulating the phenotype of the HRN mouse. The HRN and RCN models have been used to study the metabolism and genotoxicity of a variety of environmental carcinogens including benzo[a] pyrene, aristolochic acid, 3-nitrobenzanthrone and 2-amino-1-methyl-6-phenylimiazo [4,5-b] pyridine and the results obtained are summarized in this review.
For example, investigations of BaP metabolism in the HRN and RCN mice revealed an apparent paradox, whereby hepatic P450 enzymes appeared to be more important for detoxification of BaP in vivo, despite being involved in its metabolic activation in vitro. Cytochrome b(5) is a microsomal haemoprotein which provides electrons (from cytochrome b(5) reductase) to P450 enzymes; however, its role in carcinogen metabolism is still enigmatic.